Talking Law with Hogan Lovells Cadwalader

Building a resilient tech strategy is crucial to keep on top of the game. Most businesses, if they are not using technology already are probably looking into ways of using it to stay ahead of the pack. However, if your core businesses has nothing to do with tech, then you are going to need help. This is where a tech joint venture can help, but it comes with its risks. In this podcast our lawyers look into what you should watch out for when you enter one with another firm.

Being an innovative business comes with its challenges and legal risks. In recent years, there has been a major increase in cyber attacks, and this is a real risk for every business.  Aside from the cyber attack itself, businesses are increasingly facing an onslaught of litigation in the aftermath of a breach, such as consumers seeking compensation. In this podcast, our team looks at: what happens when a cyber attack occurs, and the legal aspects you should be thinking of.

Right now, every industry is under pressure to innovate, compete or even survive in the current environment, and many companies are using technology to solve some of their biggest challenges.  There are a lot of legal risks and issues that businesses may face, from a simple malfunction to a complex hack that could lead to big consequences.  In this episode we’ll look at what happens when things don’t go to plan.

Listen in on a conversation with Hilary and Hogan Lovells Corporate & Finance practice partners, Tiffany Posil and Brian O’Fahey, about the SEC’s game-changing proposed climate change disclosure rules for public companies.

In our first HL PensionsPod episode, Faye Jarvis and Duncan Buchanan, two of our Pensions partners, discuss bulk transfers to master trusts and the key issues that employers and trustees should think about.

In the final podcast of our False Claims Act Podcast Series, we're going to look ahead at a couple of legal issues where we expect developments in 2022 to affect the way FCA cases are investigated and litigated. We will also discuss the relatively new development in FCA practice - that is, the Department of Justice’s (DOJ) increased scrutiny on the role of private equity firms and companies pursued and False Claims Act cases.

Participants: Jonathan Diesenhaus and Emily Lyons
Moderator: Anthony “Tony” Fuller

The pandemic has really transformed the healthcare sector. The rise in telemedicine has rapidly changed patient care - as providers look to deliver services in a safe and effective way. And it's not going away. The use of telemedicine continues to grow. While an impressive step-change, the use of telemedicine has certainly caught the attention of the Department of Justice as well as the qui tam relators' bar. We're seeing greater enforcement actions and an increase in False Claims Act cases. Let's dig into this a bit and find out what it means for companies in this space.

Participants: Michele Sartori and Allison Caplis 
Moderator: Gejaa Gobena

Since the pandemic, cyber related crime is on the rise. And with that comes an increase in cyber fraud. Many of our clients who conduct business with the U.S. government are also keenly aware of the risks associated with the False Claims Act, which is the civil statute that permits treble damages for the government in a number of circumstances, including when a false or misleading claim for payment is made to the government. Now there is a clear intersection between these two important issues.

Participants: Michael Theis and Stacy Hadeka
Moderator: David Sharfstein

Ivan and Mark are joined by senior director Anna Weinstein and partner Cybil Roehrenbeck, members of the Government Relations and Public Affairs practice, to discuss healthcare and what could be a “must do” item for 2022.

It's been an almost perfect storm. We're seeing rapid developments in technology alongside great economic pressures brought on by the pandemic. We've also watched as a new administration settled into Washington - one that seems to take a more aggressive approach to the enforcement of corporate crime.

With Amy Roma (Washington, D.C.) and Karl Poernbacher (Munich).

With Liam Naidoo (London) and Ann Kim (Los Angeles).

With Nicola Evans (London) and Brian O'Fahey (Washington, D.C.)

With Maegen Morrison (London) and John Beckman (Washington, D.C.)

Ivan and Mark sit down with Neil Chatterjee, a new member of the firm's Energy Regulatory and Government Relations and Public Affairs practices, to discuss Neil's background and current developments happening in politics and the economy.

In part two of the discussion around Joint Ventures, Hogan Lovells partners Antonia Croke and Richard Lawton, both members of the CaSL steering committee, will give answers to the question of what happens with a Joint Venture when the relationship deteriorates and it is no longer  “love at first sight”. They will give insight into how to effectively terminate your agreement and come out of it relatively unscathed.

With Adrian Walker (London) and Jochen Seitz (Frankfurt)

With Chandri Navarro (Washington, D.C.) and Miguel Ángel Mateo Simón (Mexico City)

With Laurie Hammond (Johannesburg) and Andrew Carey (London)

With Amy Roma (Washington, D.C.) and Susan Bright (London)

In this Series 5 finale, Andrew speaks to CDC Group’s Chief Executive Officer, Nick O’Donohoe. Previously a Senior Adviser to the Bill and Melinda Gates Foundation, Nick co-founded and served as CEO of Big Society Capital. Established in 1948, CDC Group is the UK’s development finance institution with a portfolio of around £5 billion, making it the world’s first impact investor supporting businesses in Africa and South Asia.

Listen as they discuss who CDC are, what they do, and what role they can play in delivering results from an impact point of view. They explore what aspects of COVID-19 have been the most challenging in the DFI/Multilateral space; and what organisations like CDC can do to promote AfCFTA and the African Union’s call for a new paradigm. Nick talks about his views on what a ‘Just Transition’ means within an African context, and how he thinks CDC can support this. He also shares more about the group's green agenda in light of COP26 and the upcoming COP27, which is set to be held on the continent. 

Join these two industry stalwarts for a candid and insightful conversation; our last A Perspective Podcast for 2021.